Auxly Cannabis Group Inc. · TSX:XLY
Auxly Cannabis — Investor Presentation (April 2021)
24 slides from Auxly Cannabis's investor presentation, April 2021
Slide 1: This is Auxly - Investor Presentation
This ts Auxly. Investor Presentation Auxly
Slide 2: Forward-looking information disclaimer
ward- looking information, general business, The information provided herein is not intended to This corporate document contains economic and competitive uncertainties, provide financial, tax, legal or accounting advice. “foward-looking statements” and regulatory risks including risks related to the
Slide 3: Our winning formula
Our winning formula: The best team, assembled from cannabis enthusiasts and entrepreneurs, CPG professionals and renowned scientists and researchers, all with a shared commitment to quality and our consumers; the best strategy, dialed-in and focused on knowing where the consumer is headed; and the b
Slide 4: Our Vision and Mission
Our Vision: Auxly’s vision is to be a global leader in branded cannabis products that deliver on our consumer promise of quality, safety and efficacy. Our Mission: Supporting the health and happiness of our consumers by providing the quality branded cannabis products they trust and love. This is Aux
Slide 5: Auxly Snapshot
Auxly Snapshot We operate state-of-the-art cultivation, extraction, processing and manufacturing facilities across the eastern provinces and collaborate with the country’s finest craft growers to bring consistent, effective, high-quality cannabis products to Canadian consumers. ASSET R&D CULTIVATION
Slide 6: 2020 in Review
One of the top LPs leading market share in every 12% National market One of the first LPs to market with In Review 2.0 products [encoun share in edibles Launched its ne Letntain Gi brand Back ” * Kolab Project’s Forty with nS _Launch of : grower series unique high- * | Robinsons premium collaboratio
Slide 7: No. 1 LP in 2020 for Cannabis 2.0 Product Sales
No. 1 LP in 2020 for Cannabis 2.0 Product1 Sales with a 14% share of the National 2.0 Market JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC / Investor Presentation
Slide 8: Moving towards positive adjusted EBITDA by H2 2021
Moving towards positive adjusted EBITDA by H2 2021. / Investor Presentation
Slide 9: Strong growth in cannabis net revenue in 2020
Strong growth in cannabis net revenue in 2020 Net Revenue by Quarter $20 $15 4.2020 $10 12020 $5 $0 3 2020 22020 (millions) XLY Net Revenue Path to Profitability 1 2. Build upon oursuccess —_ Drive the company’s as a market leader in focused expansion of its Cannabis 2.0 Products —_cannabis'1.0 offe
Slide 10: Our Product Categories
Our Product Categories - Consistent, High-Quality And Unique VAPES: Two ingredients: EDIBLES: Made with natural, high-quality cannabis traceable ingredients and distillate and terpenes. high-quality cannabis, Available in0.3,0.5 and1.0g distillate. Our portfolio sizes,and a variety of strains _inclu
Slide 11: Cannabis 2.0 sales accounted for 27% of the Total Market
Cannabis 2.0 sales accounted for Topicals: 0% Other: 1% Edibles: 5% 27% of the Total Market. Pre Rolls: 16% Capsules: 2% Sublinguals: 4% The Canadian cannabis market is Cannabis 2.0 products continue to gain Concentrates projected to reach $10bn in sales by strong market share as new product includi
Slide 12: Ottawa pre-roll manufacturing facility
Auxly’s facility located in Ottawa, Ontario is completely focused on pre-roll product manufacturing. / Investor Presentation
Slide 13: Dosecann product formulation and manufacturing center
Dosecann is Auxly’s state-of-the art center for cannabis product formulation and manufacturing. At every stage of product development, the experience of the end-user is what we care about the most. Dosecann is committed to providing consumers with quality products backed by science and advanced rese
Slide 14: Continuously evolving our portfolio to meet consumer demands
Continuously evolving our portfolio to meet consumer demands / Investor Presentation
Slide 15: Leveraging partnerships with industry leaders
Leveraging our partnerships with industry leaders allows Auxly to better optimize its portfolio and build powerful consumer value propositions. / Investor Presentation
Slide 16: We build brands that connect
We build brands that connect. Accompanying consumers on their cannabis journeys, our commitment is to continually develop our brands to maintain an authentic connection. This is Auxly / Investor Presentation 16 Auxly
Slide 17: Kolab Project
KOLAB PROJECT A refined collection of high quality cannabis products and design-focused, purposeful goods. We connect consumers with a carefully selected group of collaborators in order to create products that are inspired by their ever-evolving needs. AVAILABLE NOW Pre-Rolls: Dried Flower: Vapes: C
Slide 18: Back Forty
Slide 19: Foray
Foray Foray is a versatile, modern, and inviting cannabis brand, designed for the curious. Foray is an accessible entry point for anybody—at any stage of their cannabis journey. Designed for the curious, Foray is an approachable brand that aims to both celebrate and guide one’s foray into cannabis,
Slide 20: Dosecann
Slide 21: Robinsons
ROBINSONS Proudly situated in the heart of Nova Scotia’s Annapolis Valley, Robinsons is a Canadian producer of fine cannabis. Always small-batch and hand-tended, our product is grown for and best enjoyed by the discerning consumer. Driven by an unwavering commitment to craftsmanship, our focus has a
Slide 22: Capitalization Table
Capitalization Table AMOUNT ($ MILLIONS) AMOUNT (UNIT) PERCENTAGE COMMON SHARES OUTSTANDING! $252.53 691.86M 70.8% STOCK OPTIONS (WEIGHTED AVERAGE EXERCISE PRICE OF $0.902) $36.88 40.89M 42% WARRANTS (WEIGHTED AVERAGE EXERCISE PRICE OF $0.593) $33.24 56.02M 5.7% IMPERIAL BRANDS CONVERTIBLE DEBENTURE
Slide 23: Board of Directors
Board of Directors Genevieve Young Chair Genevieve is the President and Chief Operating Officer of Global Public Affairs, Canada’s leading privately held strategic communications and government advocacy consultancy representing some of Canada’s largest and most dynamic organizations. Genevieve has t
Slide 24: Auxly contact details
Auxly Auxly Cannabis Group 777 Richmond St W Unit 002 Toronto Ontario M6J 0C2 Investor Relations Direct Line 1647 8120121 Facsimile Line 1 855 669 7881 Email info@auxly.com April 2021
Auxly Cannabis Group — Investor Presentation (April 2021) on 6ix